Osaic Holdings’s Acorda Therapeutics ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1
| Closed | – | – | 7715 |
|
|
2024
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 7718 |
|
|
2024
Q1 | $13 | Hold |
1
| – | – | ﹤0.01% | 7139 |
|
|
2023
Q4 | $15 | Sell |
1
-1
| -50% | -$11 | ﹤0.01% | 7219 |
|
|
2023
Q3 | $29 | Buy |
2
+1
| +100% | +$15 | ﹤0.01% | 7301 |
|
|
2023
Q2 | $13 | Buy |
+1
| New | +$12 | ﹤0.01% | 7394 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 7616 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7593 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7658 |
|
|
2022
Q2 | – | Sell |
-4
| Closed | -$71 | – | 7739 |
|
|
2022
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 7684 |
|
|
2021
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 7697 |
|
|
2021
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 7415 |
|
|
2021
Q2 | $0 | Sell |
4
-13
| -76% | -$1.14K | ﹤0.01% | 7211 |
|
|
2021
Q1 | $2K | Hold |
17
| – | – | ﹤0.01% | 6553 |
|
|
2020
Q4 | $1K | Sell |
17
-1
| -6% | -$92 | ﹤0.01% | 6320 |
|
|
2020
Q3 | $1K | Hold |
18
| – | – | ﹤0.01% | 6121 |
|
|
2020
Q2 | $1K | Hold |
18
| – | – | ﹤0.01% | 6027 |
|
|
2020
Q1 | $2K | Buy |
+18
| New | +$3.54K | ﹤0.01% | 5748 |
|
Osaic Holdings's ACOR Position: Q3 2024 in Review
Osaic Holdings sold out of Acorda Therapeutics (ACOR) in Q3 2024, closing a stake of 1 share.
Osaic Holdings first reported a position in ACOR in Q1 2020 and held it in 14 quarters. The position peaked at $2K in Q1 2021. 0 funds tracked by Wall St. Rank hold ACOR as of Q3 2024.
- Osaic Holdings reported no remaining Acorda Therapeutics position as of Q3 2024 after selling out during the quarter.
- Osaic Holdings sold 1 Acorda Therapeutics share in Q3 2024.
- Osaic Holdings first reported a position in Acorda Therapeutics in Q1 2020 and held it in 14 quarters.
- Osaic Holdings's Acorda Therapeutics position peaked at $2K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2024.
Based on Osaic Holdings's 13F filing for Q3 2024, filed 13 Nov 2024.